ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care - Episode 8
Considerations for Polycythemia Vera Management: Patient Monitoring, Outcomes, and Risks
Panelists discuss monitoring parameters when treating patients with polycythemia vera (PV), including what to assess, typical outcomes, and when treatment should be switched due to ineffectiveness. Dr Kuykendall to Dr Gangat: Panelists explore the risk of PV progression/transformation, risk factors for progression, and how the data influence patient care and treatment choices in practice.
Video content above is prompted by the following:
- What are your monitoring parameters when treating patients for PV?
- What do you assess, and what are typical outcomes for patients with PV patients?
- At what point is treatment determined to be ineffective, and should thus needing to be switched?
- Please discuss the risk of PV progression/transformation.
- What are risk factors for PV progression?
- How does the data impact patient care and treatment choices in your practice?
Related Content:
